Dr. Wernz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
220 Riverside Blvd
Apt 42B
New York, NY 10069Phone+1 212-724-4688
Education & Training
NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 1978 - 1979- New York University School of Medicine1976 - 1978
Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 1973 - 1976
University of Washington School of MedicineClass of 1973
Certifications & Licensure
CA State Medical License 1979 - Present
NY State Medical License 1974 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 278 citationsRandomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma.Parkash S. Gill, J C Wernz, David T. Scadden, P Cohen, G M Mukwaya
Journal of Clinical Oncology. 1996-08-01 - 141 citationsPhase I trial of low-dose continuous topotecan infusion in patients with cancer: an active and well-tolerated regimen.Howard S. Hochster, Leonard Liebes, James L. Speyer, Joan Sorich, Beth Taubes
Journal of Clinical Oncology. 1994-03-01 - 47 citationsEffect of prolonged topotecan infusion on topoisomerase 1 levels: a phase I and pharmacodynamic study.Howard S. Hochster, Leonard Liebes, James L. Speyer, Joan Sorich, B Taubes
Clinical Cancer Research. 1997-08-01
Grant Support
- Daunoxome For Patients With Hiv/Ks And Symptomatic Pulmonary DiseaseNational Center For Research Resources1996–1997
- Compassionate Use Of Daunoxome In Advanced Kaposi'S SarcomaNational Center For Research Resources1996–1997
- Daunoxome For Patients With Hiv/Ks And Symptomatic Pulmonary DiseaseNational Center For Research Resources1995–1996
- Daunoxome 60mg/M2 For Patients With Advanced Kaposi'S SarcomaNational Center For Research Resources1995–1996
- Daunoxome VS Adriamycin/Bleomycin/Vincristine For HIV Induced Kaposis SarcomaNational Center For Research Resources1994–1996
- Compassionate Use Of Daunoxome In Advanced Kaposi'S SarcomaNational Center For Research Resources1994–1996
- Phase II Trial Of MGBG In Hiv/Non-Hodgkin'S LymphomaNational Center For Research Resources1995
- Cgs-16949a VS Megestrol Acetate In Post-Menopausal Women With Breast CancerNational Center For Research Resources1993–1994
- Anti-B4 Blocked Ricin For HIV Associated Non-Hodgkin'S LymphomaNational Center For Research Resources1993
- 10-Edam, Vinblastine And Mitomycin Chemotherapy For Non-Small Cell Lung CancerNational Center For Research Resources1993
- 10-EDAM And Chemotherapy For Non-Small Cell Lung CancerNational Center For Research Resources1992
- 10-Ethyl-10-Deaza-Aminopterin And Chemotherapy For Non-Small Cell Lung CancerNational Center For Research Resources1991
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
